Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 6 Issue 7

Risk of Developing CVD in Women with a History of Gestational Diabetes

Farnoosh Asgharvahedi1, Leila Gholizadeh1*, Fiona Orr1 and Marjan Khajehei2

1Faculty of Health, University of Technology Sydney, NSW, Australia
2Department of Women’s and Newborn Health, Westmead Hospital, NSW, Australia

*Corresponding Author: Leila Gholizadeh, Faculty of Health, University of Technology Sydney, NSW, Australia.

Received: February 21, 2022; Published: June 10, 2022


Aims: Despite significant improvements in cardiovascular care over the past decades, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in men and women globally. Apart from traditional CVD risk factors, some gender-specific conditions contribute to the risk of CVD in women. This review investigates the relationship between gestational diabetes mellitus and CVD risk in women.

Methods: The search for the literature was conducted in MEDLINE, CINAHL, and Cochrane library, and was limited to articles published in English between January 2015 and 2020. Following the application of the study inclusion and exclusion criteria, eight studies were included in the review.

Results: The findings of this review suggest that the risk of future CVD events is higher in women with a history of gestational diabetes. The findings support the need for early cardiovascular assessment and risk factor management after the postpartum period among women with gestational diabetes.

Conclusions: Health care providers should be aware of the association between gestational diabetes and CVD risk and develop health promotion strategies to reduce the risk among this high-risk women group.

Keywords: Cardiovascular Disease; Coronary Artery Disease; Gestational Diabetes Mellitus


  1. World Health Organization. “Cardiovascular diseases (cvds) fact sheet”. World Health Organization (2017).
  2. Virani SS., et al. “Heart disease and stroke statistics-2020 update: A report from the american heart association”. Circulation 141 (2020): e139-e596.
  3. Australian Institute of Health and Welfare. Cardiovascular disease (2020).
  4. Australian Bureau of Statistics. Cause of death 2017 2018;cat. no.3303.0 (2017).
  5. Mohammadnezhad M., et al. “Common modifiable and non-modifiable risk factors of cardiovascular disease (cvd) among pacific countries”. World Journal of Cardiovascular Surgery 6 (2016): 153.
  6. Wenger NK. “Female‐friendly focus: 2019 acc/aha guideline on the primary prevention of cardiovascular disease”. Clinical Cardiology 42 (2019): 706.
  7. Asgharvahedi F., et al. “The risk of cardiovascular disease in women with a history of miscarriage and/or stillbirth”. Health Care for Women International 40 (2019): 1117-1131.
  8. Asgharvahedi FA., et al. “Hypertensive disorders of pregnancy and risk of future cardiovascular disease in women”. Nursing for Women's Health 24 (2020): 91-100.
  9. Muche AA., et al. “Prevalence and determinants of gestational diabetes mellitus in africa based on the updated international diagnostic criteria: A systematic review and meta-analysis”. Archives of Public Health 77 (2019): 36.
  10. Di Cianni G., et al. “Preventing type 2 diabetes and cardiovascular disease in women with gestational diabetes–the evidence and potential strategies”. Diabetes Research and Clinical Practice 145 (2020): 184-192.
  11. International Diabetes Federation. Gestational diabetes (2020).
  12. Newman JD., et al. “Primary prevention of cardiovascular disease in diabetes mellitus”. Journal of the American College of Cardiology 70 (2017): 883-893.
  13. Daly B., et al. “Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study”. PLoS Medicine 15 (2018).
  14. McKenzie-Sampson S., et al. “Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: A retrospective cohort study”. Acta Diabetologica 55 (2018): 315-322.
  15. Retnakaran R and Shah BR. “Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus”. Diabetes Care 40 (2017): 101-108.
  16. Tobias DK., et al. “Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of us women”. JAMA Internal Medicine 177 (2017): 1735-1742.
  17. Shostrom DC., et al. “History of gestational diabetes mellitus in relation to cardiovascular disease and cardiovascular risk factors in us women”. Frontiers in Endocrinology 8 (2017): 144.
  18. Goueslard K., et al. “Early cardiovascular events in women with a history of gestational diabetes mellitus”. Cardiovascular Diabetology 15 (2016): 15.
  19. Charach R., et al. “Can slight glucose intolerance during pregnancy predict future maternal atherosclerotic morbidity?” Diabetic Medicine 33 (2016): 920-925.
  20. Kaul P., et al. “Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: A population‐level analysis”. Diabetic Medicine 32 (2015): 164-173.
  21. Ferranti EP., et al. “Pregnancy reveals evolving risk for cardiometabolic disease in women”. Journal of Obstetric, Gynecologic and Neonatal Nursing 45 (2016): 413-425.
  22. Vinayagam D., et al. “Preeclampsia-what is to blame? The placenta, maternal cardiovascular system or both?” World Journal of Obstetric Gynecology 4 (2015): 77-85.
  23. Grandi SM., et al. “Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications: Systematic review and meta-analysis”. Circulation 139 (2019): 1069-1079.
  24. Bassily E., et al. “Significance of obstetrical history with future cardiovascular disease risk”. The American Journal of Medicine 132 (2019): 567-571.
  25. Perera MJ., et al. “Gestational diabetes and cardiovascular risk factors and disease in us hispanics/latinas in the hispanic community health study/study of latinos (hchs/sol)”. Women and Health 59 (2019): 481-495.
  26. Mosca L., et al. “Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update”. Circulation 123 (2011): 1243-1262.
  27. Carr DB., et al. “Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes”. Diabetes Care 29 (2006): 2078-2083.
  28. Corcoy R. “Glucose screening in pregnancy to predict future cardiovascular risk”. Nature Reviews Endocrinology 15 (2019): 380-382.


Citation: Leila Gholizadeh., et al. “Risk of Developing CVD in Women with a History of Gestational Diabetes”.Acta Scientific Medical Sciences 6.7 (2022): 105-111.


Copyright: © 2022 Leila Gholizadeh., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US